0 results available. Select is focused ,type to refine list, press Down to open the menu,
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform ...
The following section summarizes insights on Insulet Corporation's Revenue Growth:
We've identified the following companies as similar to Insulet Corporation because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Revenue Growth in the growth category include:
Period over prior period growth in revenue.
The revenue growth measures a company’s revenue year-over-year growth. The formula to calculate revenue growth and an example calculation for Insulet’s trailing twelve months is outlined below:
Revenue Growth = (Current Year - Prior Year) / ABS(Prior Year Revenue)*
22.1% = ($2.072 B - $1.697 B) / $1.697 B
*ABS = An absolute value adjustment is used to ensure the direction of growth of negative numbers is reflected
The tables below summarizes Insulet’s performance over the last five years:
| Fiscal Year | Revenue | Growth |
|---|---|---|
| 2020-12-31 | 904.4 M | 22.5% |
| 2021-12-31 | 1.099 B | 21.5% |
| 2022-12-31 | 1.305 B | 18.8% |
| 2023-12-31 | 1.697 B | 30.0% |
| 2024-12-31 | 2.072 B | 22.1% |
The tables below summarizes Insulet’s performance over the last four quarters:
| Quarter Ending | Revenue | Growth |
|---|---|---|
| 2024-03-31 | 441.7 M | 23.3% |
| 2024-06-30 | 488.5 M | 23.2% |
| 2024-09-30 | 543.9 M | 25.7% |
| 2024-12-31 | 597.5 M | 17.2% |
Growth calculations are always made in the company’s reporting currency to ensure currency fluctuations do not impact the calculation. Insulet’s reports in the USD currency. You can read more about Revenue here.
The chart above depicts the distribution of revenue growth for companies operating in the Healthcare sector in the Developed economic region. Over 1,920 companies were considered in this analysis, and 1,848 had meaningful values. The average revenue growth of companies in the sector is 29.8% with a standard deviation of 122.2%.
Insulet Corporation's Revenue Growth of 22.1% ranks in the 73.2% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,924 |
| Included Constituents | 1,848 |
| Min | -99.9% |
| Max | 1,404.0% |
| Median | 6.4% |
| Mean | 29.8% |
| Standard Deviation | 122.2% |
You can find companies with similar revenue growth using this stock screener.